Checkpoint Trends Ltd Stock Hits All-Time High at Rs.119.95

Jan 01 2026 09:31 AM IST
share
Share Via
Checkpoint Trends Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today as its stock price soared to an all-time high of Rs.119.95. This achievement marks a continuation of the company’s robust performance, reflecting sustained investor confidence and strong market momentum.
Checkpoint Trends Ltd Stock Hits All-Time High at Rs.119.95

Record-Breaking Price Movement

The stock opened with a notable gap up of 4.98%, immediately setting the tone for the day’s trading session. It maintained this elevated level throughout, touching an intraday high of Rs.119.95, which also represents the new 52-week peak. This price surge outpaced the broader sector’s performance by 4.88%, underscoring Checkpoint Trends Ltd’s relative strength within the Pharmaceuticals & Biotechnology industry.

Over the past four consecutive trading days, the stock has delivered a remarkable 21.52% return, signalling sustained buying interest and positive momentum. This streak of gains has contributed significantly to the stock’s current valuation, which now stands at a market cap grade of 4, reflecting its growing market capitalisation and investor appeal.

Strong Relative Performance Against Benchmarks

Checkpoint Trends Ltd’s recent performance has been exceptional when compared to key market indices. The stock’s one-day gain of 4.98% far exceeded the Sensex’s modest 0.24% rise. Over a one-week period, the stock surged 19.09%, while the Sensex remained virtually flat with a 0.02% increase. The one-month performance similarly favoured Checkpoint Trends Ltd, which climbed 18.48% against the Sensex’s slight decline of 0.26%.

More impressively, the stock’s three-month return stands at an extraordinary 140.77%, dwarfing the Sensex’s 5.48% gain. Over the past year, Checkpoint Trends Ltd has delivered an astonishing 837.84% return, a figure that starkly contrasts with the Sensex’s 8.81% rise. These figures highlight the company’s exceptional growth trajectory and its ability to outperform the broader market consistently.

Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.

  • - Investment Committee approved
  • - 50+ candidates screened
  • - Strong post-announcement performance

See Why It Was Chosen →

Long-Term Growth and Moving Averages

Checkpoint Trends Ltd’s long-term performance further emphasises its market strength. Over five years, the stock has appreciated by an extraordinary 4982.63%, vastly outperforming the Sensex’s 78.45% gain during the same period. Extending the horizon to ten years, the stock’s return reaches an impressive 8172.41%, compared to the Sensex’s 226.53% increase. These figures demonstrate the company’s sustained ability to generate value for shareholders over an extended timeframe.

Technical indicators also support the stock’s strong position. Checkpoint Trends Ltd is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a robust upward trend and positive investor sentiment. This alignment across multiple moving averages typically reflects a healthy price momentum and a favourable technical outlook.

Mojo Score and Grade Upgrade

The company’s Mojo Score currently stands at 54.0, categorised as a Hold grade. This represents a significant upgrade from its previous Sell rating, which was revised on 04 Sep 2025. The improved grade reflects enhanced financial metrics and market performance, signalling a more stable outlook relative to prior assessments. The Mojo Score and grade provide a comprehensive evaluation of the company’s fundamentals, market position, and risk profile.

Sector and Industry Context

Operating within the Pharmaceuticals & Biotechnology sector, Checkpoint Trends Ltd has demonstrated resilience and growth amid a competitive and rapidly evolving industry landscape. The company’s ability to outperform its sector peers and the broader market indices highlights its operational effectiveness and strategic positioning. The sector’s overall performance has been modest in comparison, making Checkpoint Trends Ltd’s gains particularly noteworthy.

Considering Checkpoint Trends Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this micro-cap with top-rated alternatives now!

  • - Better options discovered
  • - Pharmaceuticals & Biotechnology + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Summary of Recent Trading Activity

Checkpoint Trends Ltd’s recent trading activity has been characterised by strong upward momentum and consistent gains. The stock’s four-day consecutive rise, culminating in today’s all-time high, reflects a sustained positive trend. The opening gap of 4.98% today and the maintenance of the peak price throughout the session indicate robust demand and limited selling pressure.

Such performance is supported by the stock’s technical strength, with prices comfortably above all key moving averages. This technical backdrop, combined with the company’s fundamental improvements and upgraded Mojo Grade, paints a picture of a stock that has successfully navigated recent market conditions to reach new heights.

Market Capitalisation and Quality Assessment

Checkpoint Trends Ltd’s market cap grade of 4 suggests a mid-tier market capitalisation within its sector, reflecting a balance between growth potential and established market presence. The company’s Mojo Grade of Hold, upgraded from Sell, indicates a moderate risk-reward profile, with improvements in financial health and market performance contributing to a more favourable assessment.

While the Mojo Score of 54.0 does not place the stock in the highest tier, it signals a stable position relative to peers, supported by strong price appreciation and consistent gains over multiple timeframes.

Conclusion

Checkpoint Trends Ltd’s achievement of an all-time high at Rs.119.95 marks a significant milestone in its market journey. The stock’s exceptional returns over short, medium, and long-term periods, combined with its upgraded Mojo Grade and strong technical indicators, underscore the company’s solid performance within the Pharmaceuticals & Biotechnology sector. This milestone reflects both the company’s operational strengths and its ability to deliver sustained value to shareholders.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News